Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Asymptomatic incidence and duration of prostate cancer.

Etzioni R, Cha R, Feuer EJ, Davidov O.

Am J Epidemiol. 1998 Oct 15;148(8):775-85.

2.

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS.

J Natl Cancer Inst. 1999 Jun 16;91(12):1017-24.

3.

Prevalence-corrected prostate cancer incidence rates and trends.

Merrill RM, Morris MK.

Am J Epidemiol. 2002 Jan 15;155(2):148-52.

4.
5.
6.

The lifetime risk of developing prostate cancer in white and black men.

Merrill RM, Weed DL, Feuer EJ.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):763-8.

7.

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ.

J Natl Cancer Inst. 2002 Jul 3;94(13):981-90.

8.

Trends in prostate cancer mortality among black men and white men in the United States.

Chu KC, Tarone RE, Freeman HP.

Cancer. 2003 Mar 15;97(6):1507-16.

9.

Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.

Sarma AV, Schottenfeld D.

Semin Urol Oncol. 2002 Feb;20(1):3-9.

PMID:
11828352
10.

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

Etzioni R, Berry KM, Legler JM, Shaw P.

Urology. 2002 Feb;59(2):251-5.

PMID:
11834397
11.

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.

Merrill RM, Capocaccia R, Feuer EJ, Mariotto A.

Int J Epidemiol. 2000 Apr;29(2):197-207.

13.

Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.

Telesca D, Etzioni R, Gulati R.

Biometrics. 2008 Mar;64(1):10-9. Epub 2007 May 14.

PMID:
17501937
14.
15.

Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area.

Demers RY, Swanson GM, Weiss LK, Kau TY.

Arch Intern Med. 1994 Jun 13;154(11):1211-6.

PMID:
8203988
16.

Trends in breast cancer by race and ethnicity: update 2006.

Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M.

CA Cancer J Clin. 2006 May-Jun;56(3):168-83.

17.

Black-white differences in survival from late-stage prostate cancer.

Polednak AP.

Ethn Dis. 2003 Spring;13(2):220-5.

PMID:
12785419
18.

Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.

Whittemore AS, Cirillo PM, Feldman D, Cohn BA.

J Urol. 2005 Sep;174(3):872-6; discussion 876.

PMID:
16093978
19.

Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.

Merrill RM, Feuer EJ, Warren JL, Schussler N, Stephenson RA.

Am J Epidemiol. 1999 Oct 15;150(8):848-60.

20.

Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999.

Wu X, Chen VW, Martin J, Roffers S, Groves FD, Correa CN, Hamilton-Byrd E, Jemal A; Comparative Analysis of Incidence Rates Subcommittee, Data Evaluation and Publication Committee, North American Association of Central Cancer Registries.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1215-22.

Items per page

Supplemental Content

Write to the Help Desk